Janux Therapeutics, Inc. · NASDAQ:JANX
BlackRock, Inc. reported a 5.70% stake in Janux Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 5.70% stake in Janux Therapeutics, Inc., 3,345,664 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 3,345,664
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.70% | 3,345,664 |
Source
Related
- Janux Therapeutics, Inc.
- BlackRock, Inc.
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026
- Form 4 · RA Capital Nexus Fund II, L.P. · Jun 12, 2026